Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(17)30702-7
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2017
Authors
Publisher
Elsevier BV